SCHEMBL24977211

SCHEMBL24977211

O=C(Cl)Cc1cccc(F)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANO1 Q5XXA6 1/20 0.41
ALDH1A1 P00352 4/20 0.40
ALOX15 P16050 1/20 0.39
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
CXCL8 P10145 2/20 0.38
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MAPT P10636 1/20 0.37
MEN1 O00255 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
PNMT P11086 1/20 0.36
KDM4E B2RXH2 1/20 0.36
BCHE P06276 1/20 0.35
P2RX7 Q99572 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6259615 0.87 ALDH1A1 (0.41) ANO1ALDH1A1CES2CES1CXCL8
SCHEMBL17838502 0.85 CXCL8 (0.53) ANO1CXCL8KDM4E
SCHEMBL30285770 0.85 CXCL8 (0.53) ANO1CXCL8KDM4E
SCHEMBL24173599 0.83 ANO1 (0.43) ANO1ALDH1A1CES2CES1CXCL8
SCHEMBL1142802 0.82 CES2 (0.45) ALDH1A1ALOX15CES2CES1CXCL8
SCHEMBL3086828 0.82 PNMT (0.56) ALDH1A1CXCL8KMT2AMEN1TAAR1
SCHEMBL1124265 0.82 ALDH1A1 (0.50) ALDH1A1ALOX15CXCL8KMT2AMEN1
SCHEMBL30098315 0.82 ALDH1A1 (0.50) ALDH1A1ALOX15CXCL8KMT2AMEN1
SCHEMBL24687102 0.80 ANO1 (0.47) ANO1ALDH1A1CXCL8KMT2ACYP1A2
SCHEMBL27301664 0.79 MPO (0.41) ANO1ALDH1A1ALOX15CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-18 US disclosed
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-18 US disclosed
US-11566030-B2 Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566030-B2 Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators PDK1, PDK2, PDK3 ANO1 3553/4885ALDH1A1 1703/4885ALOX15 3911/4885
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS PDK1, PDK2, PKM ANO1 3029/4885ALDH1A1 1784/4885ALOX15 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.